A detailed history of Cahill Financial Advisors Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Cahill Financial Advisors Inc holds 3,789 shares of JNJ stock, worth $553,307. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,789
Previous 3,501 8.23%
Holding current value
$553,307
Previous $548,000 9.31%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $44,703 - $46,869
288 Added 8.23%
3,789 $599,000
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $3,348 - $3,654
23 Added 0.66%
3,501 $548,000
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $16,665 - $18,669
-107 Reduced 2.98%
3,478 $541,000
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $29,172 - $31,394
-189 Reduced 5.01%
3,585 $593,000
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $41,387 - $49,391
274 Added 7.83%
3,774 $584,000
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $287,719 - $322,902
-1,796 Reduced 33.91%
3,500 $618,000
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $164,879 - $183,469
1,022 Added 23.91%
5,296 $865,000
Q2 2022

Aug 08, 2022

BUY
$168.19 - $186.01 $8,745 - $9,672
52 Added 1.23%
4,274 $758,000
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $3,953 - $4,489
25 Added 0.6%
4,222 $748,000
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $147,665 - $163,840
-947 Reduced 18.41%
4,197 $717,000
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $13,404 - $14,896
83 Added 1.64%
5,144 $831,000
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $47,046 - $50,465
295 Added 6.19%
5,061 $834,000
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $214,604 - $239,012
1,402 Added 41.68%
4,766 $784,000
Q4 2020

Feb 17, 2021

BUY
$137.11 - $157.38 $38,390 - $44,066
280 Added 9.08%
3,364 $529,000
Q3 2020

Nov 17, 2020

BUY
$140.38 - $153.83 $7,019 - $7,691
50 Added 1.65%
3,084 $459,000
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $1,674 - $2,021
-13 Reduced 0.43%
3,034 $427,000
Q1 2020

May 18, 2020

SELL
$111.14 - $153.99 $2.09 Million - $2.9 Million
-18,842 Reduced 86.08%
3,047 $400,000
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $2.11 Million - $2.93 Million
19,013 Added 661.09%
21,889 $456,000
Q4 2019

Feb 14, 2020

SELL
$127.5 - $146.44 $25,627 - $29,434
-201 Reduced 6.53%
2,876 $419,000
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $392,783 - $439,781
-3,094 Reduced 50.14%
3,077 $398,000
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $65,050 - $71,543
-496 Reduced 7.44%
6,171 $860,000
Q1 2019

May 16, 2019

SELL
$125.72 - $139.79 $27,784 - $30,893
-221 Reduced 3.21%
6,667 $932,000
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $59,454 - $71,554
-484 Reduced 6.57%
6,888 $889,000
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $30,759 - $36,148
-253 Reduced 3.32%
7,372 $1.02 Million
Q2 2018

Aug 15, 2018

BUY
$119.4 - $131.76 $106,385 - $117,398
891 Added 13.23%
7,625 $926,000
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $52,291 - $61,922
418 Added 6.62%
6,734 $863,000
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $656 - $718
-5 Reduced 0.08%
6,316 $883,000
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $7,768 - $8,122
-60 Reduced 0.94%
6,321 $822,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,381
6,381 $845,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cahill Financial Advisors Inc Portfolio

Follow Cahill Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cahill Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cahill Financial Advisors Inc with notifications on news.